Senores Pharmaceuticals
BSE 544319
5 stories, newest first.
- Senores Q2 FY27 earnings conference call rescheduled to 04:00 P.M. IST on October 29, 2026
- Senores Pharmaceuticals to hold Q2 & H1 FY27 earnings conference call on October 29, 2026
- Board meeting on October 29, 2026 to approve Q2 and H1 results
- Board re-appoints Managing Director and Whole-time Director for three years each
- Board approves re-appointment of MD and Whole Time Director, each for three years
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.